Hypoxia Induced Downregulation of Na+/H+ Exchanger-1 Activity Decreases Tumor Cell Proliferation

Abstract

Objectives: Hypoxia and acidosis are the hallmarks of proliferative tumor microenvironment which can modulate the expression and function of Na+/H+ exchanger-1 (NHE1) via hypoxia inducible factor 1 (Hif). Here, we investigate the severity and time dependent effects of chronic hypoxia on NHE1 activity and its correlation with cell proliferation in mouse atrium tumor derived HL-1 cells. Materials and Methods: NHE1 activity was recorded using intracellular pH (pHi) sensitive dye cSNARF-1 (Leica SP5). Cell proliferation was assessed by live cell movie analyzer (Nanoentek, JuLI Br®) or immunofluorescence method. Results: According to our results, mild chronic hypoxia (2% O2, 48 hours) or shorter duration severe chronic hypoxia (1% O2, 24 hours) did not affect cell proliferation and NHE1 activity. In contrast, long term dimethyloxalylglycine (DMOG, Hif stabilizer) or zoniporide (NHE1 inhibitor) incubations (21% O2, 24/48 hours) suppressed cell proliferation. Conclusion: When our published and current results in this study interpreted together, at a critical level and duration of chronic hypoxia, Hif mediated downregulation of NHE1 activity could suppress tumor cell proliferation regardless of the well-known anti-proliferative early term direct effects of Hif. Therefore, restriction of NHE1 activity in tumor hypoxia is an important alternative target in regulating anti-proliferative action against tumor cells.

Keywords

• Cell culture techniques
• hypoxia
• sodium-hydrogen exchangers
• neoplasms

Hipoksi ile Indüklenen Na+/H+ Değiş-Tokuşcusu-1 Aktivitesindeki Azalma Tümör Hücre Proliferasyonunu Yavaşlatıyor

Abstract

Objectives: Hypoxia and acidosis are the hallmarks of proliferative tumor microenvironment which can modulate the expression and function of Na+/H+ exchanger-1 (NHE1) via hypoxia inducible factor 1 (Hif). Here, we investigate the severity and time dependent effects of chronic hypoxia on NHE1 activity and its correlation with cell proliferation in mouse atrium tumor derived HL-1 cells. Materials and Methods: NHE1 activity was recorded using intracellular pH (pHi) sensitive dye cSNARF-1 (Leica SP5). Cell proliferation was assessed by live cell movie analyzer (Nanoentek, JuLI Br®) or immunofluorescence method. Results: According to our results, mild chronic hypoxia (2% O2, 48 hours) or shorter duration severe chronic hypoxia (1% O2, 24 hours) did not affect cell proliferation and NHE1 activity. In contrast, long term dimethyloxalylglycine (DMOG, Hif stabilizer) or zoniporide (NHE1 inhibitor) incubations (21% O2, 24/48 hours) suppressed cell proliferation. Conclusion: When our published and current results in this study interpreted together, at a critical level and duration of chronic hypoxia, Hif mediated downregulation of NHE1 activity could suppress tumor cell proliferation regardless of the well-known anti-proliferative early term direct effects of Hif. Therefore, restriction of NHE1 activity in tumor hypoxia is an important alternative target in regulating anti-proliferative action against tumor cells. Keywords: Cell culture techniques, hypoxia, sodium-hydrogen exchangers, neoplasms

Keywords

• Hücre kültürü teknikleri
• hipoksi
• sodyum-hidrojen değiş-tokuşcusu
• kanser

References

1. 1. Vaughan-Jones RD, Spitzer KW, Swietach P. Intracellular pH regulation in heart. J Mol Cell Cardiol. 2009;46:318-331.
2. 2. Putney LK, Barber DL. Na-H exchange-dependent increase in intracellular pH times G2/M entry and transition. J Biol Chem. 2003;278:44645-44649.
3. 3. Wang H, Singh D, Fliegel L. The Na+/H+ antiporter potentiates growth andretinoic acid-induced differentiation of P19 embryonal carcinoma cells. J Biol Chem. 1997;272:26545-26549.
4. 4. Tannock IF. Oxygen diffusion and the distribution of cellular radiosensitivityin tumours. Br J Radiol. 1972;45:515-524.
5. 5. Hill RP, Bush RS. A new method of determining the fraction of hypoxic cells in a transplantable murine sarcoma. Radiat Res. 1977;70:141-153.
6. 6. Ke Q, Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol. 2006;70:1469-1480.
7. 7. Gardner LB, Li Q, Park MS, et al. Hypoxia inhibits G/S transition through regulation of p27 expression. Journal of Biological Chemistry. 2001;276:7919-7926.
8. 8. Goda N, Ryan HE, Khadivi B, et al. Hypoxia-inducible factor 1α is essential for cell cycle arrest during hypoxia. Molecular and Cellular Biology. 2003;23:359-369

9. 9. Gordan JD, Bertout JA, Hu CJ, et al. HIF-2α promotes hypoxic cell proliferation by enhancing c-Myc transcriptional activity. Cancer Cell. 2007;11:335-347.
10. 10. Koshiji M, Kageyama Y, Pete EA, et al. HIF-1α induces cell cycle arrest by functionally counteracting Myc. Embo Journal. 2004;23:1949-1956.
11. 11. Hubbi ME, Kshitiz, Gilkes DM, et al. A Nontranscriptional Role for HIF-1α as a Direct Inhibitor of DNA Replication. Science Signaling. 2013;6.
12. 12. Hubbi ME, Luo WB, Baek JH, et al. MCM Proteins Are Negative Regulators of Hypoxia-Inducible Factor 1. Molecular Cell. 2011;42:700-712.
13. 13. Lal A, Peters H, St Croix B, et al. Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst. 2001;93:1337-1343.
14. 14. De Milito A, Fais S. Tumor acidity, chemoresistance and proton pump inhibitors. Future Oncol. 2005;1:779-786.
15. 15. Claycomb WC, Lanson NA, Jr., Stallworth BS, et al. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci U S A. 1998;95:2979-2984.
16. 16. Simsek G, Vaughan-Jones RD, Swietach P, et al. Recovery from hypoxiainduced internalization of cardiac Na(+) /H (+) exchanger 1 requires an adequate intracellular store of antioxidants. J Cell Physiol. 2019;234:4681-4694.
17. 17. Leem CH, Lagadic-Gossmann D, Vaughan-Jones RD. Characterization of intracellular pH regulation in the guinea-pig ventricular myocyte. J Physiol. 1999;517 ( Pt 1):159-180.
18. 18. Kandilci HB, Richards MA, Fournier M, et al. Cardiomyocyte Na/H Exchanger-1 Activity Is Reduced in Hypoxia. Frontiers in Cardiovascular Medicine. 2021;7.
19. 19. Niesyto K, Lyzniak W, Skonieczna M, et al. Biological In Vitro Evaluation of PIL Graft Conjugates: Cytotoxicity Characteristics. Int J Mol Sci. 2021;22.
20. 20. Hulikova A, Harris AL, Vaughan-Jones RD, et al. Regulation of intracellular pH in cancer cell lines under normoxia and hypoxia. J Cell Physiol. 2013;228:743-752.
21. 21. Ambrose LJ, Abd-Jamil AH, Gomes RS, et al. Investigating mitochondrial metabolism in contracting HL-1 cardiomyocytes following hypoxia and pharmacological HIF activation identifies HIF-dependent and independent mechanisms of regulation. J Cardiovasc Pharmacol Ther. 2014;19:574-585.
22. 22. Chan MC, Ilott NE, Schodel J, et al. Tuning the Transcriptional Response to Hypoxia by Inhibiting Hypoxia-inducible Factor (HIF) Prolyl and Asparaginyl Hydroxylases. J Biol Chem. 2016;291:20661-20673.
23. 23. Nagel S, Papadakis M, Chen R, et al. Neuroprotection by dimethyloxalylglycine following permanent and transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 2011;31:132-143.
24. 24. Hubbi ME, Semenza GL. Regulation of cell proliferation by hypoxiainduciblefactors. Am J Physiol Cell Physiol. 2015;309:C775-782.
25. 25. Emami Nejad A, Najafgholian S, Rostami A, et al. The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment. Cancer Cell Int. 2021;21:62.
26. 26. Zhong H, De Marzo AM, Laughner E, et al. Overexpression of hypoxiainducible factor 1α in common human cancers and their metastases. Cancer Research. 1999;59:5830-5835.
27. 27. Begley CG, Ellis LM. Drug development: Raise standards for preclinical cancer research. Nature. 2012;483:531-533.
28. 28. Hutchinson L, Kirk R. High drug attrition rates--where are we going wrong? Nat Rev Clin Oncol. 2011;8:189-190.
29. 29. Eagle H. The effect of environmental pH on the growth of normal and malignant cells. J Cell Physiol. 1973;82:1-8.
30. 30. Moser SC, Bensaddek D, Ortmann B, et al. PHD1 links cell-cycle progression to oxygen sensing through hydroxylation of the centrosomal protein Cep192. Dev Cell. 2013;26:381-392.
31. 31. Semenza GL. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol (1985). 2000;88:1474-1480.
32. 32. Shimoda LA, Fallon M, Pisarcik S, et al. HIF-1 regulates hypoxic induction of NHE1 expression and alkalinization of intracellular pH in pulmonary arterial myocytes. Am J Physiol Lung Cell Mol Physiol. 2006;291:L941-949.
33. 33. Nakamura K, Kamouchi M, Kitazono T, et al. Role of NHE1 in calcium signaling and cell proliferation in human CNS pericytes. Am J Physiol Heart Circ Physiol. 2008;294:H1700-1707.
34. 34. Yu L, Hales CA. Silencing of sodium-hydrogen exchanger 1 attenuates the proliferation, hypertrophy, and migration of pulmonary artery smooth muscle cells via E2F1. Am J Respir Cell Mol Biol. 2011;45:923-930.
35. 35. Zhang Q, Gu J, Li L, et al. Control of cyclin D1 and breast tumorigenesis by the EglN2 prolyl hydroxylase. Cancer Cell. 2009;16:413-424.
36. 36. Elvidge GP, Glenny L, Appelhoff RJ, et al. Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition: the role of HIF-1alpha, HIF-2alpha, and other pathways. J Biol Chem. 2006;281:15215-15226.
37. 37. Joung YH, Lim EJ, Lee MY, et al. Hypoxia activates the cyclin D1 promoter via the Jak2/STAT5b pathway in breast cancer cells. Exp Mol Med. 2005;37:353- 364.
38. 38. Jeong W, Jung S, Bazer FW, et al. Hypoxia-dependent accumulation of hypoxia-inducible factor-1 alpha induces transient cell cycle arrest in porcine trophectoderm cells. Theriogenology. 2018;115:9-15.
39. 39. Rolver MG, Elingaard-Larsen LO, Andersen AP, et al. Pyrazine ring-based Na(+)/H(+) exchanger (NHE) inhibitors potently inhibit cancer cell growth in 3D culture, independent of NHE1. Sci Rep. 2020;10:5800.
40. 40. Pedersen AK, Mendes Lopes de Melo J, Morup N, et al. Tumor microenvironment conditions alter Akt and Na(+)/H(+) exchanger NHE1 expression in endothelial cells more than hypoxia alone: implications for endothelial cell function in cancer. BMC Cancer. 2017;17:542.